CLNN

Clene Inc. is a pioneering clinical-stage pharmaceutical company based in Salt Lake City, Utah, dedicated to developing innovative clean-surface nanotechnology (CSN) therapies targeting neurodegenerative diseases and other significant health challenges. With a commitment to conducting thorough clinical trials, Clene aims to secure regulatory approvals for its promising product pipeline, positioning itself as a potential leader in the biopharmaceutical sector. The company’s strong scientific foundation and forward-looking strategy align well with the interests of institutional investors seeking growth opportunities in the evolving healthcare landscape.